Exercise and Movement to Enhance Resiliency in Cancer Patients (NCT06809933)
EMPOWER: Exercise and Movement to Promote Our Patients With (Gynecologic) Cancer to Enhance Resiliency
🩺 Plain-English Summary (8th-Grade Level)
This is a single-center, pilot, hybrid type 1 design implementation study to evaluate the feasibility and implementation of a personalized digital exercise program and a virtual support group to improve patient-centered outcomes in patients receiving treatment for gynecologic cancer receiving treatment at University of California, San Francisco.
Who can join: Review the eligibility criteria below.
Location: University of California, San Francisco — San Francisco, California
Age range: 18 Years
🧪 Interventions in This Study
- Digital Health Mobile App (OTHER)
- Virtual Support Group (OTHER)
- Health Coaching (OTHER)
- FitBit (OTHER)
- Handouts (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- University of California, San Francisco — San Francisco, California
📞 Contact the Study Coordinator
Phone: (877) 827-3222
Email: EMPOWER@ucsf.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Gynecologic Cancer
- Journey Ahead: Enhancing Coping and Communication for Women Diagnosed With Gynecological Cancer — New Brunswick, New Jersey
- Patient Related Outcomes for Gynecologic Radiation Oncology — Chapel Hill, North Carolina
- Optimizing Brachytherapy Application and Delivery With MRI Guidance for Gynecologic Cancer — Boston, Massachusetts
- Feasibility Study: IGNITE-TX (Identifying Individuals for Genetic Testing & Treatment) Intervention — Houston, Texas
- Impact of Cultural and Linguistic Backgrounds on Patient Care and Experience of Women With Gynecologic Malignancies — Toronto, Ontario
- Intraperitoneal FT536 in Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer — Minneapolis, Minnesota
Explore by condition: All Gynecologic Cancer clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.